← FDA Drug Approvals (Drugs@FDA)

SUNITINIB MALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-11-30

Drug application

FDA Application #

ANDA213803

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUNITINIB MALATE

Generic name

SUNITINIB MALATE

Active ingredients

SUNITINIB MALATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2021-11-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown